SCHEMBL6804332

SCHEMBL6804332

COc1cc(OC)cc(-c2c3nc(cc4ccc([nH]4)c(-c4cc(OC)cc(OC)c4)c4nc(cc5ccc2[nH]5)C=C4)C=C3)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.59
▸ STAT1 P42224 1/20 0.59
▸ TERT O14746 4/20 0.38
▸ ABCG2 Q9UNQ0 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TOP1 P11387 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2E1 P05181 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C8 P10632 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2942315 0.97 STAT3 (0.56) STAT3STAT1TERTABCG2ALDH1A1
SCHEMBL4266558 0.89 STAT3 (0.63) STAT3STAT1TERTABCG2ALDH1A1
SCHEMBL31055740 0.88 STAT3 (0.62) STAT3STAT1ALDH1A1HPGDSMN1; SMN2
SCHEMBL585528 0.88 STAT3 (0.62) STAT3STAT1ALDH1A1HPGDSMN1; SMN2
SCHEMBL9590030 0.87 STAT3 (0.60) STAT3STAT1TERTABCG2ALDH1A1
SCHEMBL2948398 0.86 STAT3 (0.60) STAT3STAT1ALDH1A1HPGDSMN1; SMN2
SCHEMBL8996959 0.86 STAT3 (0.59) STAT3STAT1TERTABCG2ALDH1A1
SCHEMBL585368 0.85 STAT3 (0.45) STAT3STAT1TERTABCG2MAPT
SCHEMBL17687652 0.85 STAT3 (0.57) STAT3STAT1TERTKDM4EMEN1
SCHEMBL498495 0.84 TERT (0.51) TERTABCG2ALDH1A1HSD17B10TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1305317-B1 DIHYDROPORPHYRIN DERIVATIVES AND THEIR USES ANULM ASS NATAISE POUR L UTILI (FR) 2004-09-15 — — EP disclosed
US-20040022734-A1 Dihydroporphyrin derivatives and their uses ANNULM, ASSOCIATION NANTAISE POUR L'UTILISATION DE LA LUMIERE EN MEDECINE (FR) 2004-02-05 — — US disclosed
EP-1305317-A1 DIHYDROPORPHYRIN DERIVATIVES AND THEIR USES Anulm Association Nataise pour l'Utilisation de la Lumière en Medicine (FR) 2003-05-02 — — EP disclosed
WO-2002010173-A1 DIHYDROPORPHYRIN DERIVATIVES AND THEIR USES ANULM ASSOCIATION NATAISE POUR L'UTILISATION DE LA LUMIERE EN MEDECINE (FR) 2002-02-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040022734-A1 Dihydroporphyrin derivatives and their uses PPOX, PPIF, DHPS STAT3 2489/4885STAT1 4379/4885TERT 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback